Publicacions - Fundació Institut d'Investigació en Ciències de la

Soriano V, Mocroft A, Peters L, Rockstroh J, Antunes F, Kirkby N, de Wit S, Monforte A, Flisiak R,
Lundgren J; EuroSIDA. (R. Paredes as member of the EuroSIDA Study Group)
Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in
Europe. J ANTIMICROB CHEMOTH 2010 Mar;65(3):548-55
IF: 4,659
Steigbigel RT, Cooper DA, Teppler H, Eron JJ, Gatell JM, Kumar PN, Rockstroh JK, Schechter M, Katlama
C, Markowitz M, Yeni P, Loutfy MR, Lazzarin A, Lennox JL, Clotet B, Zhao J, Wan H, Rhodes RR,
Strohmaier KM, Barnard RJ, Isaacs RD, Nguyen BY; BENCHMRK Study Teamsa.
Long-term efficacy and safety of Raltegravir combined with optimizedbackground therapy in treatmentexperienced
patients with drugresistantHIV infection: week 96 results of the BENCHMRK 1 and 2Phase
III trials.
CLIN INFECT DIS 2010 Feb 15;50(4):605-12.
IF: 8,186
Van den Eynde, E; Tiraboschi, JM; Tural, C; Sola, R; Mira, JA; Podzamczer, D; Jou, A; Canete, N; Pineda,
JA; Pahissa, A; Crespo, M
Ability of treatment week 12 viral response to predict long-term outcome in genotype 1 hepatitis C
virus/HIV coinfected patients
AIDS 2010; APR 24, 24 (7) 975-982
IF: 6,348
Vieira, CR; Munoz-Olaya, JM; Sot, J; Jimenez-Baranda, S; Izquierdo-Useros, N; Abad, JL; Apellaniz, B;
Delgado, R; Martinez-Picado, J; Alonso, A; Casas, J; Nieva, JL; Fabrias, G; Manes, S; Goni, FM
Dihydrosphingomyelin Impairs HIV-1 Infection by Rigidifying Liquid-Ordered Membrane Domains
CHEM BIOL 2010; jul-30, 17 (7) 766-775
IF: 5,838
Worm SW, Friis-Møller N, Bruyand M, D'Arminio Monforte A, Rickenbach M, Reiss P, El-Sadr W, Phillips
A, Lundgren J, Sabin C; D:A:D study group. (R. Paredes as member of the EuroSIDA Study Group)
High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of
the metabolic syndrome.
AIDS 2010 Jan 28;24(3):427-35
IF: 6,348
Projectes
BLANCO ARBUES, JULIAN MIGUEL
FIS - Núm. Exp.: PI081306
Herramientas para la cuantificación de la respuesta humoral protectiva contra las proteínas gp120 y gp41
del VIH. Análisis de indicadores de protección y diseño racional de inmunógenos.
Durada: 3 anys - (2008-2011)
Import Concedit: 61.200 €
BLANCO ARBUES, JULIAN MIGUEL
FIPSE - Núm. Exp.: 36750/08
Evaluación de la adenosina desaminasa como molécula coestimuladora de la actividad linfocitaria en una
vacuna terapéutica del VIH.
Durada: 3 anys - (2008-2011)
Import Concedit: 27.350 €
Pàgina 57 de 148